TAIPEI, Feb. 19, 2025 /PRNewswire/ -- NaviFUS Corp. is dedicated to advancing non-invasive treatments for complex brain disorders, a challenging area in medical innovation. By using ultrasound ...
Visit a quote page and your recently viewed tickers will be displayed here.
NaviFUS Corp., a medical device company, develops and sells focused ultrasound (FUS) solutions for the unmet needs in neuromedicine in Taiwan. The company develops NaviFUS, a neuronavigator-guided ...
This clinical trial is funded by the Focused Ultrasound Foundation. TAIPEI, Aug. 4, 2021 /PRNewswire/ -- NaviFUS' focused ultrasound (FUS) therapy system (NaviFUS®) was recently approved for use in a ...
TAIPEI, Sept. 11, 2020 /PRNewswire/ -- Genovate Biotech (TPEX:4130) subsidiary and Taiwan-based focused ultrasound (FUS) manufacturer NaviFUS Corporation is pleased to announce the start of its ...
NaviFUS Corp. NaviFUS Corp. operates as a medical device company. It provides solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. The firm's NaviFUS System, is ...
TAIPEI, Aug. 3, 2021 /PRNewswire/ -- NaviFUS' focused ultrasound (FUS) therapy system (NaviFUS®) was recently approved for use in a new clinical trial by the Taiwan Food and Drug Administration (TFDA) ...
This clinical trial is funded by the Focused Ultrasound Foundation. The principle behind the "synergy" of this combined treatment is based on findings that the blood flow and oxygen concentration in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results